{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T14:45:23Z","timestamp":1745333123892},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.clinthera.2012.06.026","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T00:47:40Z","timestamp":1343695660000},"page":"1705-1719","source":"Crossref","is-referenced-by-count":12,"title":["I-COMBINE Study: Assessment of Efficacy and Safety Profile of Irbesartan\/Amlodipine Fixed-Dose Combination Therapy Compared With Amlodipine Monotherapy in Hypertensive Patients Uncontrolled With Amlodipine 5 mg Monotherapy: A Multicenter, Phase III, Prospective, Randomized, Open-Label With Blinded\u2013End Point Evaluation Study"],"prefix":"10.1016","volume":"34","clinical-trial-number":[{"clinical-trial-number":"nct00956644","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Guillaume","family":"Bobrie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2012.06.026_bib1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2012.06.026_bib2","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2012.06.026_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2012.06.026_bib4","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.HYP.0000165020.14745.79","article-title":"Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome","volume":"45","author":"Wang","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2012.06.026_bib5","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2012.06.026_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00003495-200262030-00003","article-title":"Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats","volume":"62","author":"Sica","year":"2002","journal-title":"Drugs"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2012.06.026_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1524-6175.2003.02674.x","article-title":"Creating a combination antihypertensive regimen: what does the research show?","volume":"5","author":"Weber","year":"2003","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.clinthera.2012.06.026_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0895-7061(02)02279-3","article-title":"A comparison of candesartan, felodipine, and their combination in the treatment of elderly patients with systolic hypertension","volume":"15","author":"Morgan","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2012.06.026_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1751-7176.2008.07516.x","article-title":"Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study","volume":"10","author":"Allemann","year":"2008","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.clinthera.2012.06.026_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.clinthera.2008.04.002","article-title":"The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study","volume":"30","author":"Chrysant","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2012.06.026_bib11","article-title":"Hypertension: the clinical management of primary hypertension in adults","year":"2011","journal-title":"National Clinical Guideline Centre"},{"key":"10.1016\/j.clinthera.2012.06.026_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/sj.jhh.1002140","article-title":"Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients","volume":"21","author":"Fogari","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.clinthera.2012.06.026_bib13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2165\/00003495-200464090-00011","article-title":"Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy","volume":"64","author":"Croom","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2012.06.026_bib14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2165\/00003495-199550030-00009","article-title":"Amlodipine","volume":"50","author":"Haria","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2012.06.026_bib15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2165\/00003495-200767090-00005","article-title":"Dihydropyridine calcium channel antagonists in the management of hypertension","volume":"67","author":"Epstein","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2012.06.026_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockroft","year":"1976","journal-title":"Nephron"},{"key":"10.1016\/j.clinthera.2012.06.026_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00126097-200202000-00002","article-title":"Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults","volume":"7","author":"O'Brien","year":"2002","journal-title":"Blood Press Monit"},{"key":"10.1016\/j.clinthera.2012.06.026_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1524-6175.2007.06689.x","article-title":"Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies","volume":"9","author":"Smith","year":"2007","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.clinthera.2012.06.026_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clinthera.2007.03.018","volume":"29","author":"Philipp","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2012.06.026_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/jhh.2008.153","article-title":"Efficacy and safety of initial combination therapy with amlodipine\/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study","volume":"23","author":"Flack","year":"2009","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.clinthera.2012.06.026_bib21","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.archger.2008.03.012","article-title":"Efficacy and safety of two treatment combinations of hypertension in very elderly patients","volume":"48","author":"Fogari","year":"2009","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.clinthera.2012.06.026_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.109.131300","article-title":"Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial","volume":"54","author":"Calhoun","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2012.06.026_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/HJH.0b013e32834000a7","article-title":"Moderate versus intensive treatment of hypertension with amlodipine\/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy","volume":"29","author":"Oparil","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2012.06.026_bib24","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2012.06.026_bib25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/VHRM.S2586","article-title":"Fixed combinations in the management of hypertension: patients perspectives and rationale for development and utility of the olmesartan-amlodipine combination","volume":"4","author":"Pimenta","year":"2008","journal-title":"Vasc Health Risk Manag"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181200389X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181200389X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T09:01:39Z","timestamp":1562058099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929181200389X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S014929181200389X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.06.026","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}